RxDoctor Payments Data

Spencer Amundsen, MD

Orthopaedic Surgery · Draper, UTNPI 1841517257

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (50.4%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Smith+Nephew at 37.8% of the total. Reporting peaked in 2022 at $5,774 and has fallen 76.2% since, to $1,377 in 2025.

$17,696in general payments, 2019–2025

Across 134 payments — averaging $132.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$7K
  • Stryker$4K
  • Medacta USA, Inc.$3K
  • Encore Medical, LP$2K
  • Pacira Pharmaceuticals Incorporated$1K
  • Johnson & Johnson$833
  • plus $272 from 5 others

What the payments were for

  • Consulting fees$2,75016%
  • Speaking & faculty fees$1,5008%
  • Travel & lodging$8,91250%
  • Food & beverage$4,53526%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,696 in reported general payments places this provider in the 70th percentile of 221 orthopaedic surgery providers in Utah.

See all orthopaedic surgery providers in Utah

Medicare billing

Part B allowed, 2024
$231,061
Medicare patients
314
Services billed
1,745

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib13$557
Mupirocin30$220
Meloxicam34$180
Amoxicillin81$97

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Draper

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →